Clinical Trial Update: Tocilizumab for Renal Graft Inflammation [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating tocilizumab for inflammatory complications after kidney transplant has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complication From Kidney Transplant
• Kidney Transplant Rejection or Late Complication of Kidney Transplant

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: Flavio Vincenti | Conditions: Late Complication From Kidney Transplant | Phase 2 | Status: COMPLETED | Results posted: 2021-01-27